295 related articles for article (PubMed ID: 28648300)
1. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effect of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on enhancing antitumor activity of cisplatin in ascites sarcoma 180 cells.
Sato T; Okubo M; Sawaki K; Maehashi H; Kawaguchi M
J Pharmacol Sci; 2010; 112(3):361-8. PubMed ID: 20197637
[TBL] [Abstract][Full Text] [Related]
3. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
[TBL] [Abstract][Full Text] [Related]
4. DMSA, DMPS, and DMPA--as arsenic antidotes.
Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
[TBL] [Abstract][Full Text] [Related]
5. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
6. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
[TBL] [Abstract][Full Text] [Related]
7. Antidotal effects of 2,3-dimercaptopropane-1-sulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the organotoxicity of dibutyltin dichloride (DBTC) in rats.
Merkord J; Weber H; Kröning G; Hennighausen G
Hum Exp Toxicol; 2000 Feb; 19(2):132-7. PubMed ID: 10773844
[TBL] [Abstract][Full Text] [Related]
8. Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2.
Wang G; Bi Y; Xiong H; Bo T; Han L; Zhou L; Zhang C; Zhang Y
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S447-S459. PubMed ID: 34592875
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
10. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
Bridges CC; Joshee L; Zalups RK
J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
[TBL] [Abstract][Full Text] [Related]
12. Effects of meso-2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate on beryllium-induced biochemical alterations and metal concentration in male rats.
Flora SJ; Mathur S; Mathur R
Toxicology; 1995 Jan; 95(1-3):167-75. PubMed ID: 7825183
[TBL] [Abstract][Full Text] [Related]
13. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
14. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
Gale GR; Smith AB; Jones MM; Singh PK
Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
[TBL] [Abstract][Full Text] [Related]
15. Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.
Iwata K; Aizawa K; Kamitsu S; Jingami S; Fukunaga E; Yoshida M; Yoshimura M; Hamada A; Saito H
Clin Exp Nephrol; 2012 Dec; 16(6):843-51. PubMed ID: 22569819
[TBL] [Abstract][Full Text] [Related]
16. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
18. Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
Filipski KK; Mathijssen RH; Mikkelsen TS; Schinkel AH; Sparreboom A
Clin Pharmacol Ther; 2009 Oct; 86(4):396-402. PubMed ID: 19625999
[TBL] [Abstract][Full Text] [Related]
19. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
Bjørklund G; Mutter J; Aaseth J
Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
[TBL] [Abstract][Full Text] [Related]
20. [Platinum agent-induced nephrotoxicity via organic cation transport system].
Yonezawa A
Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]